Welcome to Dwaey, specifically on Elemental Iron (Iron sucrose) page.
This medicine contains important and useful components, as it consists of
Elemental Iron (Iron sucrose) is available in the market in concentration.
Elemental Iron (Iron sucrose)
Before starting iron sucrose (elemental iron), it is crucial for patients to consult their healthcare provider to ensure safe and appropriate use. Important precautions include:
- Iron Overload: Iron sucrose should not be used in patients with iron overload disorders (such as hemochromatosis or hemosiderosis) since excessive iron accumulation can cause organ damage.
- Anemia Diagnosis: It is essential to confirm that anemia is caused by iron deficiency before starting iron sucrose treatment. It should not be used for anemia caused by non-iron deficiencies (e.g., vitamin B12 or folic acid deficiency).
- Hypersensitivity: Patients with a history of hypersensitivity or allergic reactions to iron sucrose or other iron compounds should avoid using this medication.
- Pregnancy and Lactation: While iron sucrose is generally considered safe during pregnancy, it should only be used when clearly necessary and under a healthcare provider’s guidance. The drug is excreted in breast milk in small amounts, but it is considered safe for use during breastfeeding.
- Cardiovascular Conditions: Iron sucrose should be used with caution in patients with cardiovascular conditions, particularly in those who have fluid retention (e.g., heart failure) or those receiving medications that affect blood volume.
- Renal Dysfunction: Iron sucrose is commonly administered to patients with chronic kidney disease (CKD) and is generally safe. However, it should be used under careful monitoring of kidney function and iron levels, especially in patients with end-stage renal disease or those on dialysis.
Iron sucrose is primarily prescribed for the treatment of iron deficiency anemia. Its main therapeutic uses include:
- Iron Deficiency Anemia in Chronic Kidney Disease: Iron sucrose is commonly used to treat iron deficiency anemia in patients with chronic kidney disease, especially those undergoing hemodialysis or peritoneal dialysis. It is given intravenously to replenish iron stores quickly.
- Iron Deficiency Anemia in Other Conditions: It is also used to treat iron deficiency anemia in patients who cannot tolerate oral iron supplements or in situations where rapid correction of iron deficiency is needed (e.g., patients with gastrointestinal malabsorption, significant blood loss, or those requiring iron therapy in a hospital setting).
- Supportive Therapy During Cancer Treatment: Iron sucrose may be used in patients receiving cancer treatments, such as chemotherapy, where anemia can result due to the treatment's impact on red blood cell production.
Iron sucrose is contraindicated in the following conditions:
- Iron Overload: It is contraindicated in patients with iron overload disorders, including hemochromatosis and hemosiderosis, as these conditions cause excess iron storage in the body.
- Hypersensitivity: Patients who are hypersensitive to iron sucrose or any of its components should avoid using the medication, as it can lead to allergic reactions, which may be severe.
- Anemia Due to Non-Iron Causes: If anemia is not due to iron deficiency (e.g., anemia caused by vitamin B12 or folic acid deficiency, bone marrow disorders), iron sucrose should not be administered.
Iron sucrose is generally well tolerated, but like all medications, it may cause side effects. Common and serious side effects include:
- Common Side Effects:
- Gastrointestinal Discomfort: Abdominal pain, nausea, vomiting, and diarrhea are common when receiving intravenous iron therapy.
- Headache and Dizziness: These can occur, especially when administering the medication via IV.
- Injection Site Reactions: Pain, redness, or swelling at the injection site is common with intravenous iron therapy.
- Serious Side Effects:
- Allergic Reactions: Severe allergic reactions, including anaphylaxis, have been reported with intravenous iron sucrose. Symptoms can include rash, difficulty breathing, and swelling of the face or throat. These reactions require immediate medical attention.
- Iron Overload: In cases of excessive dosing or concurrent iron therapy, iron overload can occur, leading to symptoms such as joint pain, fatigue, and damage to organs like the liver, heart, and pancreas.
- Hypotension: Hypotension (low blood pressure) is a potential side effect, especially during or after the administration of IV iron sucrose. This can cause dizziness, fainting, and heart palpitations.
- Phlebitis: Inflammation of the vein (phlebitis) at the injection site may occur, especially if the infusion rate is too rapid or if the iron solution is injected improperly.
Patients should report any severe side effects, particularly signs of allergic reactions or iron toxicity, to their healthcare provider immediately.
2
Iron sucrose works by supplying the body with elemental iron, which is essential for the production of hemoglobin in red blood cells. Its mechanism of action includes:
- Iron Delivery to the Bloodstream: When administered intravenously, iron sucrose provides elemental iron directly into the bloodstream, bypassing the gastrointestinal tract, which can be advantageous for patients who cannot absorb iron orally or for those with gastrointestinal conditions that limit iron absorption.
- Restoration of Hemoglobin: Once the iron is delivered into the bloodstream, it is incorporated into red blood cells to form hemoglobin, the oxygen-carrying protein in the blood. This increases the oxygen-carrying capacity of the blood and alleviates the symptoms of anemia.
- Increase in Iron Stores: Iron sucrose also helps replenish iron stores in the body, which are necessary for the ongoing production of red blood cells, reducing the need for ongoing supplementation.
Iron sucrose may interact with other medications, affecting its efficacy or increasing the risk of adverse effects:
- Antacids: Taking iron sucrose with antacids or proton pump inhibitors may reduce the absorption and effectiveness of the iron supplement.
- Oral Iron Supplements: Concomitant use of oral iron supplements or other intravenous iron formulations can increase the risk of iron overload, particularly in patients who do not require additional iron.
- Medications Affecting Renal Function: Iron sucrose should be used cautiously in patients taking medications that affect kidney function (such as ACE inhibitors or ARBs), as this could increase the risk of renal complications.
- Chronic Blood Thinners or Anticoagulants: Patients on blood-thinning medications (such as warfarin) may require dose adjustments, as the concurrent use of iron sucrose could lead to changes in the absorption and effect of anticoagulants.
The dose of iron sucrose is typically determined based on the patient’s weight and the severity of their iron deficiency. The general adult dosing guidelines are:
- Iron Deficiency Anemia (Non-dialysis patients):
- The usual dose is 100 mg to 200 mg of iron sucrose per week, administered via slow intravenous infusion.
- The total cumulative dose over a period of treatment is often based on the patient's calculated iron deficit and the desired iron levels.
- Dialysis Patients:
- For patients undergoing hemodialysis, iron sucrose is often given in doses ranging from 100 to 200 mg intravenously, with the number of doses depending on the severity of anemia and the individual patient’s response.
Infusions are typically spaced out over several weeks, and doses are adjusted according to the patient’s iron levels and hemoglobin response.
Iron sucrose can be used in pediatric patients with iron deficiency anemia, but the dosage must be adjusted based on the child’s age, weight, and clinical condition:
- Children (6 months and older): The recommended dose for children is typically 2 to 3 mg of elemental iron per kg of body weight per week, administered intravenously. Dosing adjustments should be based on the child’s hemoglobin levels and iron stores.
- Infants: In infants, iron sucrose should be used with caution, and dosing should be based on careful medical assessment.
Iron sucrose should be administered under healthcare supervision, and dosing adjustments should be made based on iron levels and the patient’s clinical response.
---
As always, it is important for patients to consult their healthcare provider before starting iron sucrose to ensure it is the appropriate medication for their condition and to discuss any potential risks or interactions.
For patients with renal impairment, particularly those on hemodialysis:
- Chronic Kidney Disease (CKD) patients on Dialysis: The recommended dose is typically 100 to 200 mg intravenously, administered after each dialysis session. The total iron dose is usually tailored based on the patient’s iron levels and needs.
- Renal Dysfunction without Dialysis: Use caution and carefully monitor iron levels to avoid iron overload, as iron sucrose is commonly used in patients with chronic kidney disease but may need to be adjusted depending on renal function.
Not available in a medicine form yet